The World Mosquito Program (WMP) is a not-for-profit group of companies owned by Australia's Monash University that works to protect the global community from mosquito-borne diseases such as dengue, Zika, yellow fever, and chikungunya. The World Mosquito Program uses naturally occurring bacteria called Wolbachia to reduce the ability of mosquitoes to transmit viruses that cause life-threatening diseases throughout tropical countries of the world. Following years of laboratory research, independent risk analysis and successful field trials, WMP has undertaken deployments in 13 countries around the world and has widespread support from communities, governments and public health regulators. We are now undergoing rapid organisational change to position WMP to play a key role in scaling global access to Wolbachia and helping to protect the 4 billion people worldwide who live at risk of dengue and other mosquito transmitted viral diseases. WMP is funded by governments and philanthropists around the world. More information about the WMP can be obtained from www.worldmosquitoprogram.org.